| Regulatory aspects on nanomedicines V Sainz, J Conniot, AI Matos, C Peres, E Zupancic, L Moura, LC Silva, ... Biochemical and biophysical research communications 468 (3), 504-510, 2015 | 345 | 2015 |
| Immunization with mannosylated nanovaccines and inhibition of the immune-suppressing microenvironment sensitizes melanoma to immune checkpoint modulators J Conniot, A Scomparin, C Peres, E Yeini, S Pozzi, AI Matos, R Kleiner, ... Nature nanotechnology 14 (9), 891-901, 2019 | 183 | 2019 |
| Poly (lactic acid)-based particulate systems are promising tools for immune modulation C Peres, AI Matos, J Conniot, V Sainz, E Zupančič, JM Silva, L Graca, ... Acta biomaterialia 48, 41-57, 2017 | 134 | 2017 |
| Nanoparticle impact on innate immune cell pattern-recognition receptors and inflammasomes activation AL Silva, C Peres, J Conniot, AI Matos, L Moura, B Carreira, V Sainz, ... Seminars in immunology 34, 3-24, 2017 | 89 | 2017 |
| Nanotechnology is an important strategy for combinational innovative chemo-immunotherapies against colorectal cancer AI Matos, B Carreira, C Peres, LIF Moura, J Conniot, T Fourniols, ... Journal of Controlled Release 307, 108-138, 2019 | 58 | 2019 |
| Functionalized branched polymers: promising immunomodulatory tools for the treatment of cancer and immune disorders LIF Moura, A Malfanti, C Peres, AI Matos, E Guegain, V Sainz, M Zloh, ... Materials Horizons 6 (10), 1956-1973, 2019 | 52 | 2019 |
| α-Galactosylceramide and peptide-based nano-vaccine synergistically induced a strong tumor suppressive effect in melanoma V Sainz, LIF Moura, C Peres, AI Matos, AS Viana, AM Wagner, ... Acta biomaterialia 76, 193-207, 2018 | 34 | 2018 |
| Preclinical models and technologies to advance nanovaccine development C Peres, AI Matos, LIF Moura, RC Acurcio, B Carreira, S Pozzi, ... Advanced Drug Delivery Reviews 172, 148-182, 2021 | 26 | 2021 |
| 5α-Dihydrotestosterone regulates the expression of L-type calcium channels and calcium-binding protein regucalcin in human breast cancer cells with suppression of cell growth R Marques, CG Peres, CV Vaz, IM Gomes, MI Figueira, E Cairrao, I Verde, ... Medical Oncology 32, 1-11, 2015 | 19 | 2015 |
| Polymer-based nanoparticles as modern vaccine delivery systems L Lambricht, C Peres, H Florindo, V Préat, G Vandermeulen Micro and nanotechnology in vaccine development, 185-203, 2017 | 18 | 2017 |
| Functional moieties for intracellular traffic of nanomaterials AL Silva, LIF Moura, B Carreira, J Conniot, AI Matos, C Peres, V Sainz, ... Biomedical applications of functionalized nanomaterials, 399-448, 2018 | 9 | 2018 |
| Optimization of protein loaded PLGA nanoparticle manufacturing parameters following a quality-by-design approach V Sainz, C Peres, T Ciman, C Rodrigues, AS Viana, CAM Afonso, ... RSC advances 6 (106), 104502-104512, 2016 | 9 | 2016 |
| Development of Chitosan Particles Loaded with siRNA for Cystatin C to Control Intracellular Drug-Resistant Mycobacterium tuberculosis D Pires, M Mandal, AI Matos, C Peres, MJ Catalão, JM Azevedo-Pereira, ... Antibiotics 12 (4), 729, 2023 | 7 | 2023 |
| Polyoxazoline‐Based Nanovaccine Synergizes with Tumor‐Associated Macrophage Targeting and Anti‐PD‐1 Immunotherapy against Solid Tumors AI Matos, C Peres, B Carreira, LIF Moura, RC Acúrcio, T Vogel, ... Advanced Science 10 (25), 2300299, 2023 | 6 | 2023 |
| Translational peptide-associated nanosystems: promising role as cancer vaccines E Zupancic, C Peres, A I Matos, J Lopes, J N Moreira, R S Gaspar, ... Current Topics in Medicinal Chemistry 16 (3), 291-313, 2016 | 4 | 2016 |
| Nanomedicines as Multifunctional Modulators of Melanoma Immune Microenvironment B Carreira, RC Acúrcio, AI Matos, C Peres, S Pozzi, D Vaskovich‐Koubi, ... Advanced Therapeutics, 2000147, 2020 | 3 | 2020 |
| Flow cytometric methodology for the detection of de novo human T-cell leukemia virus-1 infection in vitro: A tool to study novel infection inhibitors C Peres, Y Tanaka, F Martin, J Fox Journal of virological methods 274, 113728, 2019 | 3 | 2019 |
| Immunomodulation against microbial pathogens through dendritic cells JM Silva, E Zupancic, C Peres, LC Silva, R Gaspar, V Préat, HF Florindo Microbial Pathogens and Strategies for Combating Them: Science Technolgy and …, 2013 | 3 | 2013 |
| Specialized Tfh cell subsets driving type-1 and type-2 humoral responses in lymphoid tissue S Kumar, AP Basto, F Ribeiro, SCP Almeida, P Campos, C Peres, ... Cell Discovery 10 (1), 64, 2024 | 2 | 2024 |
| Multifunctional Nanovaccine Sensitizes Breast Cancer to Immune Checkpoint Therapy C Peres, AI Matos, B Carreira, LIF Moura, R Kleiner, D Vaskovich‐Koubi, ... Advanced Functional Materials, 2401749, 2024 | 2 | 2024 |
Helena F. FlorindoProfessor, University of Lisbon在 ff.ul.pt 的电子邮件经过验证
